{
    "SPADE_N_14573": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14573",
            "Peptide Name": "Y7T,V16R (Synthetic AMPs, PG-1 analog, Arg-rich, 2S=S, UCSS1a)",
            "Source": "amino acid SUBSTITUTION, pig cathelicidin analog, animal-derived, natural derivatives",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "RGGRLCTCRRRFCVCRGR",
            "Sequence Length": 18,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2155.61,
            "PI": 11.61,
            "Hydrophobicity": -0.7,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Bolosov IA, Panteleev PV, Sychev SV, Khokhlova VA, Safronova VN, Toropygin IY, Kombarova TI, Korobova OV, Pereskokova ES, Borzilov AI, Ovchinnikova TV, Balandin SV.2023",
                    "Reference": "Pharmaceutics. 2023 Jul 30;15(8):2047. doi: 10.3390/pharmaceutics15082047.PubMed",
                    "Title": "Design of Protegrin-1 Analogs with Improved Antibacterial Selectivity."
                }
            ],
            "Frequent Amino Acids": "RCG",
            "Absent Amino Acids": "ADEHIKMNOPQSUWY",
            "Basic Residues": 7,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 3,
            "Polar Residues": 13,
            "Positive Residues": 7,
            "Negative Residues": 0,
            "Net Charge": 7,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (88.89%) toProtegrin 1R: 39%, C: 22%, G: 17%.Activity: active against E. coli ATCC 25922 or ML35p or BW 25113 (MIC 4-8 uM), P-aeruginosa PAO1 or ATCC 27853 (MIC>32 uM), A. baumannii (MIC 4 uM), K-pneumoniae ATCC 700603 (MIC >32 uM), S-aureus 209P or ATCC 29213 (MIC >32 uM), and M. luteus B-1314 (MIC 4 uM).In vitro toxicity: 1.4% hemo.lytic at 64 uM, much less than WT PG-1 (96% hemolysis).Recombinant production:bacteria:Escherichia coli: recombinant peptide was obtained and used.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_07318",
                    "Similarity": 1.0,
                    "Sequence": "VSRRRRRRGGRRRR"
                },
                {
                    "SPADE_ID": "SPADE_N_11055",
                    "Similarity": 1.0,
                    "Sequence": "KNKRKRRRRRRGGRRRR"
                },
                {
                    "SPADE_ID": "SPADE_UN_11384",
                    "Similarity": 1.0,
                    "Sequence": "TLISWIKNKRKQRPRVSRRRRRRGGRRRR"
                }
            ]
        }
    }
}